Abstract Background Coronaviruses (CoVs) primarily cause enzootic infections in birds and
mammals but, in the last few decades, have shown to be capable of infecting humans as …

Human coronavirus (HCoV) infection causes respiratory diseases with mild to severe
outcomes. In the last 15 years, we have witnessed the emergence of two zoonotic, highly …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a devastating
global pandemic, which has seriously affected human health worldwide. The discovery of …

Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) is a novel epidemic
strain of Betacoronavirus that is responsible for the current viral pandemic, coronavirus …

Post-translational modifications (PTMs) refer to the covalent modifications of polypeptides
after they are synthesized, adding temporal and spatial regulation to modulate protein …

COVID-19 is one of the most impactful pandemics in recorded history. As such, the
identification of inhibitory drugs against its etiological agent, SARS-CoV-2, is of utmost …

Coronavirus (CoV) outbreaks have recently emerged as a global public health threat due to
their exceptional zoonotic potential—a feature arising from their ability to infect a diverse …

Coronaviruses (CoVs) assemble by budding into the lumen of the early Golgi complex prior
to exocytosis. The small CoV envelope (E) protein plays roles in assembly, virion release …

The Envelope (E) protein in SARS Coronavirus (CoV) is a small structural protein,
incorporated as part of the envelope. A major fraction of the protein has been known to be …

Coronavirus (CoV) envelope (E) protein is a small structural protein critical for virion
morphogenesis and release. The recently characterized E protein ion channel activity (EIC) …